Continuous 28 day iododeoxyuridine (IUdR) infusion and hyperfractionated accelerated radiotherapy (HART) for malignant glioma: A phase I clinical and thymidine replacement study. Conference

Schulz, CA, Mehta, MP, Robins, HI et al. (1997). Continuous 28 day iododeoxyuridine (IUdR) infusion and hyperfractionated accelerated radiotherapy (HART) for malignant glioma: A phase I clinical and thymidine replacement study. . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 39(2), 139-139. 10.1016/S0360-3016(97)80567-6

Open Access

cited authors

  • Schulz, CA; Mehta, MP; Robins, HI; Badie, B; Arzoomanian, R; Simon, K; Alberti, D; Feierabend, C; Kunugi, KA; Wilding, G; Kinsella, TJ

sustainable development goals

authors

publication date

  • January 1, 1997

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • PERGAMON-ELSEVIER SCIENCE LTD

start page

  • 139

end page

  • 139

volume

  • 39

issue

  • 2